The deep brain stimulation devices market is anticipated to grow at a CAGR of 10.33% from US$1,979.749 million in 2025 to ...

The company’s MySalvia system uses neuromodulation to alleviate the frequency and intensity of chronic migraines.

Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its fourth quarter ...

Persons with Parkinson's disease increasingly lose their mobility over time and are eventually unable to walk. Hope for these ...

An Ohio music conductor battling Parkinson's has found relief with adaptive deep brain stimulation, nearly eliminating ...

An Ohio music conductor is using deep brain stimulation to combat his Parkinson’s disease. Rand Laycock, 70, the director and conductor of a symphony orchestra, was diagnosed just before his ...

If deep brain stimulation (DBS) can help people with Parkinson’s disease walk and speak again, could it help people with Alzheimer’s disease, too? It’s a natural question, and one that ...